Avoro Capital Advisors LLC - TG THERAPEUTICS INC ownership

TG THERAPEUTICS INC's ticker is TGTX and the CUSIP is 88322Q108. A total of 179 filers reported holding TG THERAPEUTICS INC in Q2 2020. The put-call ratio across all filers is 0.57 and the average weighting 0.2%.

Quarter-by-quarter ownership
Avoro Capital Advisors LLC ownership history of TG THERAPEUTICS INC
ValueSharesWeighting
Q1 2020$7,872,000
-29.1%
800,000
-20.0%
0.27%
-18.4%
Q4 2019$11,100,000
-43.0%
1,000,000
-78.9%
0.33%
-72.0%
Q4 2018$19,475,000
-17.2%
4,750,000
+13.1%
1.16%
+7.8%
Q3 2018$23,520,000
-63.9%
4,200,031
-15.2%
1.08%
-56.9%
Q2 2018$65,093,000
-12.3%
4,950,031
-5.3%
2.51%
-29.3%
Q1 2018$74,261,000
+174.9%
5,229,619
+58.7%
3.55%
+102.5%
Q4 2017$27,015,0003,294,4631.75%
Other shareholders
TG THERAPEUTICS INC shareholders Q2 2020
NameSharesValueWeighting ↓
Lion Point Capital, LP 839,128$27,926,0005.24%
RA Capital Management 4,098,332$136,392,0001.89%
KLK CAPITAL MANAGEMENT LLC 45,762$1,523,0001.40%
Antara Capital LP 520,800$17,332,0001.33%
Spotlight Asset Group, Inc. 75,000$2,496,0001.24%
Nicholas Investment Partners, LP 485,838$16,169,0001.18%
MAVERICK CAPITAL LTD 3,296,451$109,706,0001.11%
SECTORAL ASSET MANAGEMENT INC 394,949$13,144,0001.09%
683 Capital Management, LLC 828,271$27,565,0001.08%
ACT CAPITAL MANAGEMENT, LLC 60,000$1,997,0001.04%
View complete list of TG THERAPEUTICS INC shareholders